San Francisco, California (PRWEB) June 10, 2014
The global market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020, growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.
Clinical oncology nanotechnology applications dominated the overall market in 2013, accounting for 35% of total market revenue. Higher efficacy of nanomaterials and the ability of engineered nanoparticles to cross through the blood brain barrier provides platform for groundbreaking innovations through R&D in the field of cancer therapy and serves this market as a high impact rendering driver.
The report Healthcare Nanotechnology (Nanomedicine) Market Analysis By Application (Drug Delivery System, Molecular Diagnostics, Clinical Oncology, Clinical Neurology, Clinical cardiology, Anti-inflammatory, Anti-infective) And Segment Forecasts To 2020, is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology.
Request free sample of this report @ http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology/request.
Further key findings from the study suggest:
Browse all Biotechnology Market Reports available at Grand View Research @ http://www.grandviewresearch.com/industry/biotechnology.
For the purpose of this study, Grand View Research has segmented the global healthcare nanotechnology market on the basis of fields of application and region:
Browse all Grand View Research Upcoming Reports @ http://www.grandviewresearch.com/ongoing-reports.
Latest Report By Grand View Research: